651 results on '"Mario M"'
Search Results
2. Adenoid cystic carcinoma of the Bartholin's gland is underpinned by MYB- and MYBL1- rearrangements
3. 2023 changes to FIGO endometrial cancer staging: Counterpoint
4. Oncologic outcomes of robot-assisted laparoscopy versus conventional laparoscopy for the treatment of apparent early-stage endometrioid adenocarcinoma of the uterus
5. Molecular subtyping in endometrial cancer: A promising strategy to guide fertility preservation
6. Impact of postoperative morbidity on outcomes in patients with advanced epithelial ovarian cancer undergoing intestinal surgery at the time of primary or interval cytoreductive surgery: A Memorial Sloan Kettering Cancer Center Team Ovary study
7. Isolated vaginal recurrence in women with stage I endometrial cancer
8. Laparoscopy with or without robotic assistance does not negatively impact long-term oncologic outcomes in patients with uterine serous carcinoma
9. Patient-reported symptoms after minimally invasive hysterectomy and association with postoperative complications
10. Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma
11. Germline drivers of gynecologic carcinosarcomas
12. Final survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical cancer: An NRG oncology randomized study
13. The MEMORY Study: MulticentEr study of Minimally invasive surgery versus Open Radical hYsterectomy in the management of early-stage cervical cancer: Survival outcomes
14. Non-exenterative surgical management of recurrent endometrial carcinoma
15. Tertiary cytoreduction for recurrent ovarian carcinoma: An updated and expanded analysis
16. Sentinel lymph node biopsy in patients with endometrial cancer and an indocyanine green or iodinated contrast reaction - A proposed management algorithm
17. Uterine serous carcinoma
18. Genetic and molecular subtype heterogeneity in newly diagnosed early- and advanced-stage endometrial cancer
19. The impact of tumor fragmentation in patients with stage I uterine leiomyosarcoma on patterns of recurrence and oncologic outcome
20. Impact of provider volume on front-line chemotherapy guideline compliance and overall survival in elderly patients with advanced ovarian cancer
21. Electronic patient-reported symptom monitoring in patients recovering from ambulatory minimally invasive gynecologic surgery: A prospective pilot study
22. The impact of near-infrared angiography and proctoscopy after rectosigmoid resection and anastomosis performed during surgeries for gynecologic malignancies
23. Incidence of pelvic lymph node metastasis using modern FIGO staging and sentinel lymph node mapping with ultrastaging in surgically staged patients with endometrioid and serous endometrial carcinoma
24. Impact of hospital volume on surgical management and outcomes for early-stage cervical cancer
25. Minimally invasive surgery versus laparotomy for radical hysterectomy in the management of early-stage cervical cancer: Survival outcomes
26. Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomy
27. Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma
28. Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer
29. Sentinel lymph node mapping alone compared to more extensive lymphadenectomy in patients with uterine serous carcinoma
30. Laparoscopy with or without robotic assistance does not negatively impact long-term oncologic outcomes in patients with uterine serous carcinoma
31. Role of lymphadenectomy in endometrial cancer with nonbulky lymph node metastasis: Comparison of comprehensive surgical staging and sentinel lymph node algorithm
32. Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma
33. Germline drivers of gynecologic carcinosarcomas
34. Molecular profiling and molecular classification of endometrioid ovarian carcinomas
35. Secondary surgical resection for patients with recurrent uterine leiomyosarcoma
36. Ultrastaging of negative pelvic lymph nodes to decrease the true prevalence of isolated paraaortic dissemination in endometrial cancer
37. Brain metastasis in epithelial ovarian cancer by BRCA1/2 mutation status
38. Risk-based stratification of carcinomas concurrently involving the endometrium and ovary
39. Patterns of FIRST recurrence of stage IIIC1 endometrial cancer with no PARAAORTIC nodal assessment
40. Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: A sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy
41. Less versus more radical surgery in stage IB1 cervical cancer: A population-based study of long-term survival
42. Minimally invasive hysterectomy surgery rates for endometrial cancer performed at National Comprehensive Cancer Network (NCCN) Centers
43. Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease
44. Trocar site hernia development in patients undergoing robotically assisted or standard laparoscopic staging surgery for endometrial cancer
45. A modern-day experience with Brunschwig's operation: Outcomes associated with pelvic exenteration
46. Surgical site infection reduction bundle in patients with gynecologic cancer undergoing colon surgery
47. Minimal access surgery compared to laparotomy for secondary surgical cytoreduction in patients with recurrent ovarian carcinoma: Perioperative and oncologic outcomes
48. A comparative analysis of prediction models for complete gross resection in secondary cytoreductive surgery for ovarian cancer
49. Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?
50. Three versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma – A multi-institutional cohort
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.